Accuray (ARAY) Competitors $1.70 -0.06 (-3.41%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$1.85 +0.15 (+8.59%) As of 05:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARAY vs. OFIX, ANGO, SRDX, RMTI, ABT, ISRG, BSX, SYK, MDT, and BDXShould you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), AngioDynamics (ANGO), Surmodics (SRDX), Rockwell Medical (RMTI), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), and Becton, Dickinson and Company (BDX). These companies are all part of the "health care equipment" industry. Accuray vs. Its Competitors Orthofix Medical AngioDynamics Surmodics Rockwell Medical Abbott Laboratories Intuitive Surgical Boston Scientific Stryker Medtronic Becton, Dickinson and Company Orthofix Medical (NASDAQ:OFIX) and Accuray (NASDAQ:ARAY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, media sentiment, dividends, profitability, analyst recommendations, institutional ownership and risk. Which has higher earnings and valuation, OFIX or ARAY? Accuray has lower revenue, but higher earnings than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrthofix Medical$799.49M0.73-$126M-$3.17-4.67Accuray$458.51M0.42-$1.59M-$0.02-85.00 Which has more volatility & risk, OFIX or ARAY? Orthofix Medical has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Accuray has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Do insiders and institutionals have more ownership in OFIX or ARAY? 89.8% of Orthofix Medical shares are held by institutional investors. Comparatively, 64.1% of Accuray shares are held by institutional investors. 1.3% of Orthofix Medical shares are held by insiders. Comparatively, 4.4% of Accuray shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor OFIX or ARAY? In the previous week, Orthofix Medical and Orthofix Medical both had 5 articles in the media. Orthofix Medical's average media sentiment score of 0.69 beat Accuray's score of 0.50 indicating that Orthofix Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orthofix Medical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Accuray 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate OFIX or ARAY? Orthofix Medical presently has a consensus target price of $21.75, indicating a potential upside of 47.06%. Accuray has a consensus target price of $5.00, indicating a potential upside of 194.12%. Given Accuray's higher probable upside, analysts clearly believe Accuray is more favorable than Orthofix Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orthofix Medical 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Accuray 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is OFIX or ARAY more profitable? Accuray has a net margin of -0.35% compared to Orthofix Medical's net margin of -15.29%. Accuray's return on equity of -4.92% beat Orthofix Medical's return on equity.Company Net Margins Return on Equity Return on Assets Orthofix Medical-15.29% -25.43% -14.46% Accuray -0.35%-4.92%-0.58% SummaryAccuray beats Orthofix Medical on 8 of the 15 factors compared between the two stocks. Get Accuray News Delivered to You Automatically Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ARAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARAY vs. The Competition Export to ExcelMetricAccurayMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$198.39M$7.00B$6.04B$10.51BDividend YieldN/A1.18%5.73%4.80%P/E Ratio-85.0026.7984.7027.24Price / Sales0.4227.55514.31200.41Price / Cash39.4821.5837.5761.53Price / Book2.365.1812.316.74Net Income-$1.59M$178.09M$3.32B$276.59M7 Day Performance1.19%-2.86%-1.33%-0.47%1 Month Performance5.59%5.12%8.13%7.47%1 Year Performance-9.09%5.21%73.08%34.58% Accuray Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARAYAccuray4.444 of 5 stars$1.70-3.4%$5.00+194.1%-5.6%$198.39M$458.51M-85.001,040Gap UpOFIXOrthofix Medical2.9059 of 5 stars$14.17-3.0%$21.75+53.5%-8.1%$577.01M$799.49M-4.471,616ANGOAngioDynamics4.2059 of 5 stars$11.26-3.3%$19.33+71.7%+76.9%$479.57M$292.50M-14.44760SRDXSurmodics4.5608 of 5 stars$28.70-1.4%$43.00+49.8%-28.0%$416.35M$126.08M-23.33450News CoveragePositive NewsRMTIRockwell Medical3.4787 of 5 stars$1.21-0.8%$4.00+230.6%-65.6%$42.01M$101.49M-20.17300ABTAbbott Laboratories4.9564 of 5 stars$133.63-0.7%$145.39+8.8%+13.6%$234.25B$41.95B16.75114,000Positive NewsAnalyst ForecastISRGIntuitive Surgical4.9419 of 5 stars$449.69-0.6%$594.19+32.1%-10.5%$162.16B$8.35B62.7215,638Trending NewsUpcoming EarningsAnalyst ForecastBSXBoston Scientific4.9048 of 5 stars$96.73-0.6%$120.79+24.9%+9.9%$144.20B$16.75B57.5853,000Positive NewsUpcoming EarningsSYKStryker4.9651 of 5 stars$365.99-1.2%$430.33+17.6%+2.9%$141.64B$22.60B48.4853,000Positive NewsAnalyst ForecastMDTMedtronic4.8568 of 5 stars$98.46+0.8%$100.94+2.5%+7.3%$125.32B$33.54B27.1295,000Positive NewsBDXBecton, Dickinson and Company4.9455 of 5 stars$191.94-0.9%$205.40+7.0%-21.5%$55.49B$20.18B34.5274,000Positive News Related Companies and Tools Related Companies OFIX Alternatives ANGO Alternatives SRDX Alternatives RMTI Alternatives ABT Alternatives ISRG Alternatives BSX Alternatives SYK Alternatives MDT Alternatives BDX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ARAY) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
